Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Clear all

1,452 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200028
200135
200241
200344
200452
200550
200656
200766
200855
200947
201041
201155
201258
201358
201461
201542
201649
201759
201861
201961
202046
202162
202236
202346
202466
202553
202671

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed743
Terminated211
Recruiting168
Active, not recruiting113
Unknown status103
Withdrawn67
Not yet recruiting41
Suspended6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)95
M.D. Anderson Cancer Center47
Memorial Sloan Kettering Cancer Center38
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins27
University Health Network, Toronto25
University of Washington21
Jonsson Comprehensive Cancer Center19
OHSU Knight Cancer Institute19
Dana-Farber Cancer Institute18
Mayo Clinic18

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms1,452
Neoplasm Metastasis64
Neoplasms55
Breast Neoplasms41
Carcinoma, Non-Small-Cell Lung21
Adenocarcinoma20
Colorectal Neoplasms20
Lung Neoplasms20
Ovarian Neoplasms19
Pancreatic Neoplasms16

Trials

Showing 51 to 75 of 1,452. Each trial links to its page on Pharma Observatory.

1,352 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.